Skip to main content
SpringerLink
Log in

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

The first aim of this study was to compare the hypoxia imaging ability of fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) with that of fluorine-18 fluoromisonimidazole ([18F]FMISO) in murine tumours of different sizes under two different oxygenation conditions. Secondly, we wanted to assess the biodistribution of the markers in normal tissues under similar conditions. Female CDF1 mice with a C3H mammary carcinoma grown on their backs were used. Tumours were size matched and animals breathed either normal air (21% O2) or carbogen gas (95% O2 + 5% CO2). The gassing procedure was begun 5 min before the intravenous injection of either [18F]FETNIM or [18F]FMISO and continued until the mice were sacrificed at 120 min. Blood, tumour, muscle, heart, lung, liver, kidney and fat were removed, counted for radioactivity and weighed. The tumour and muscle were frozen and cut with a cryomicrotome into sections. The spatial distribution of radioactivity from the tissue sections was determined with digital autoradiography. Estimation of the necrotic fraction was made on sections from formalin-fixed tumours. Digital autoradiography showed that the whole tumour-to-muscle radioactivity uptake ratios were significantly higher in normal air-breathing mice than in carbogen-treated mice for both [18F]FETNIM (4.9±2.6 vs 1.8±0.5; P<0.01) and [18F]FMISO (4.4±1.0 vs 1.5±0.4; P<0.01). The carbogen treatment had only slight effects on the biodistribution of either marker in normal tissues. The necrotic fraction determined in tumours did not correlate with the tumour volume or with the tumour-to-muscle radioactivity uptake ratio. This study shows that the uptake of both [18F]FETNIM and [18F]FMISO correlates with the oxygenation status in tumours. In addition, our data show no significant difference in the intratumoral uptake between the two markers. However, significantly higher radioactivity uptake values were measured for [18F]FMISO than for [18F]FETNIM in normal tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2A, B
Fig. 3
Fig. 4 A

Similar content being viewed by others

References

  1. Moulder JE, Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 1984; 10:695–712.

    CAS  PubMed  Google Scholar 

  2. Overgaard J, Horsman MR. Modification of hypoxia induced radioresistance in tumours by the use of oxygen and sensitizers. Semin Radiat Oncol 1996; 6:10–21.

    PubMed  Google Scholar 

  3. Chaplin DJ, Horsman MR, Trotter MJ, Siemann DW. Therapeutic significance of microenvironmental factors. In: Molls M, Vaupel P, eds. Medical radiobiology: blood perfusion and microenvironment of human tumours. Heidelberg Berlin New York: Springer; 1998:133–143.

  4. Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56:4509–4515.

    CAS  PubMed  Google Scholar 

  5. Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000; 57:39–43.

    Article  CAS  PubMed  Google Scholar 

  6. Horsman M. Measurement of tumor oxygenation. Int J Radiat Oncol Biol Phys 1998; 42:701–704.

    Article  CAS  PubMed  Google Scholar 

  7. Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol 1998; 46:229–237.

    Article  CAS  PubMed  Google Scholar 

  8. Varghese AJ, Gulyas S, Mohindra JK. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res 1976; 36:3761–3765.

    CAS  PubMed  Google Scholar 

  9. Chapman JD. Hypoxic sensitizers—implications for radiation therapy. N Engl J Med 1979; 301:1429–1432.

    CAS  PubMed  Google Scholar 

  10. Chapman JD, Franko AJ, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer 1981; 43:546–550.

    CAS  PubMed  Google Scholar 

  11. Franko AJ, Chapman JD. Binding of14C-misonidazole to hypoxic cells in V79 spheroids. Br J Cancer 1982; 45:694–699.

    CAS  PubMed  Google Scholar 

  12. Raleigh JA, Franko AJ, Koch CJ, Born JL. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label. Br J Cancer 1985; 51:229–235.

    CAS  PubMed  Google Scholar 

  13. Rasey J, Koh WJ, Grierson JR, Grunbaum Z, Krohn KA. Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiation Oncology Biol Phys 1989; 17:985–991.

    CAS  Google Scholar 

  14. Kubota K, Tada M, Yamada S, Hori K, Saito S, Iwata R, Sato K, Fukuda H, Ido T. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med 1999; 26:750–757.

    Article  CAS  PubMed  Google Scholar 

  15. Rasey J, Casciari JJ, Hofstrand PD, Muzi M, Graham MM, Chin LK. Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole. Radiat Res 2000; 153:84–92.

    CAS  PubMed  Google Scholar 

  16. Bentzen L, Keiding S, Horsman MR, Falborg L, Hansen SB, Overgaard J. Feasibility of detecting hypoxia in experimental mouse tumours with18F-fluorinated tracers and positron emission tomography; a study evaluating [18F]fluoromisonidazole and [18F]fluoro-2-deoxyglucose. Acta Oncol 2000; 39:629–637.

    Article  CAS  PubMed  Google Scholar 

  17. Tochon-Danguy HJ, Sachinidis JI, Chan F, Gordon Chan J, Hall C, Cher L, Stylli S, Hill J, Kaye A, Scott AM. Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO). Nucl Med Biol 2002; 29:191–197.

    Article  CAS  PubMed  Google Scholar 

  18. Bentzen L, Keiding S, Horsman MR, Gronroos T, Hansen SB, Overgaard J. Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements: influence of tumour volume and carbogen breathing. Acta Oncol 2002; 41:304–312.

    Article  CAS  PubMed  Google Scholar 

  19. Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, Krohn KA, Griffin TW. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 1992; 22:199–212.

    CAS  PubMed  Google Scholar 

  20. Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med 1992; 33:2133–2137.

    CAS  PubMed  Google Scholar 

  21. Rasey JS, Koh WJ, Evans ML, Peterson LM, Lewellen TK, Graham MM, Krohn KA. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996; 36:417–428.

    CAS  PubMed  Google Scholar 

  22. Yeh SH, Liu RS, Wu LC, Yang DJ, Yen SH, Chang CW, Yu TW, Chou KL, Chen KY. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma. Eur J Nucl Med 1996; 23:1378–1383.

    CAS  PubMed  Google Scholar 

  23. Rajendran JG, Wilson DC, Conrad EU, Peterson LM, Bruckner JD, Rasey JS, Chin LK, Hofstrand PD, Grierson JR, Eary JF, Krohn KA. [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 2003; 30:695–704.

    CAS  PubMed  Google Scholar 

  24. Bentzen L, Keiding S, Nordsmark M, Falborg L, Hansen SB, Keller J, Nielsen OS, Overgaard J. Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 2003; 67:339–344.

    Article  CAS  PubMed  Google Scholar 

  25. Yang DJ, Wallace S, Cherif A, Chun L, Gretzer MB, Kim EE, Podoloff DA. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. Radiology 1995; 194:795–800.

    CAS  PubMed  Google Scholar 

  26. Chung JK, Chang YS, Lee YJ, Kim YJ, Jeong JM, Lee DS, Jang JJ, Lee MC. The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model. Ann Nucl Med 1999; 13:303–308.

    CAS  PubMed  Google Scholar 

  27. Grönroos T, Eskola O, Lehtiö K, Minn H, Marjamäki P, Bergman J, Haaparanta M, Forsback S, Solin O. Pharmacokinetics of [18F]FETNIM: a potential hypoxia marker for PET. J Nucl Med 2001; 42:1397–1404.

    Google Scholar 

  28. Lehtiö K, Oikonen V, Grönroos T, Eskola O, Kalliokoski K, Bergman J, Solin O, Grénman R, Nuutila P, Minn H. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [15O]H2O and [18F]fluoroerythronitroimidazole PET. J Nucl Med 2001; 42:1643–1652.

    Google Scholar 

  29. Lehtiö K, Oikonen V, Nyman S, Grönroos T, Roivanen A, Eskola O, Minn H. Quantifying tumor hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using tumor-to-plasma ratio. Eur J Nucl Med Mol Imaging 2003; 30:101–108.

    Article  PubMed  Google Scholar 

  30. Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys 1980; 6:1507–1517.

    CAS  PubMed  Google Scholar 

  31. Horsman MR, Khalil AA, Siemann DW, Grau C, Hill SA, Lynch EM, Chaplin DJ, Overgaard J. Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. Int J Radiat Oncol Biol Phys 1994; 29:439–442.

    CAS  PubMed  Google Scholar 

  32. Olive PL, Horsman MR, Grau C, Overgaard J. Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay. Br J Cancer 1997; 76:694–699.

    CAS  PubMed  Google Scholar 

  33. Lim JL, Berridge MS. An efficient radiosynthesis of [18F]fluoromisonimidazole. Appl Radiat Isot 1993; 44:1085–1091.

    Article  CAS  PubMed  Google Scholar 

  34. Grau C, Horsman MR, Overgaard J. Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model. Int J Radiat Oncol Biol Phys 1992; 22:421–424.

    CAS  PubMed  Google Scholar 

  35. Horsman MR, Siemann DW, Nordsmark M, Khalil AA, Overgaard J, Chaplin DJ. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment. In: Hogan MC, Mathieu-Costello O, Poole DC, Wagner PD, eds. Oxygen transport to tissue XVI. New York: Plenum; 1994:635–642.

  36. Lewis JS, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch M. Evaluation of64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med 1999; 40:177–183.

    Google Scholar 

  37. Horsman MR, Khalil AA, Nordsmark M, Grau C, Overgaard J. Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model. Radiother Oncol 1993; 28:69–71.

    CAS  PubMed  Google Scholar 

  38. Nordsmark M, Grau C, Horsman MR, Jorgensen HS, Overgaard J. Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model. Acta Oncol 1995; 34:329–334.

    CAS  PubMed  Google Scholar 

  39. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49:6449–6465.

    CAS  PubMed  Google Scholar 

  40. Khalil AA, Horsman MR, Overgaard J. The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation. Acta Oncol 1995; 34:297–300.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Lauri Sillanmäki, M.Sc., for assistance with the statistical analysis. Thanks are also expressed to Ms. T. Marttila, Ms. I.M. Horsman, Ms. M. Andersen, Ms. D. Grand, Ms. P. Schjerbeck and Mr. M. Johannsen for excellent technical assistance. This study was supported by several grants from Gustaf Packalens Mindefond, the Cultural Society of Finland and Denmark, the Danish Cancer Society and the Southwestern Finland Cancer Foundation.

Author information

Authors and Affiliations

  1. Medicity Research Laboratory, Turku PET Centre, Tykistökatu 6 A, 20520, Turku, Finland

    Tove Grönroos, Päivi Marjamäki, Olli Eskola, Merja Haaparanta, Heikki Minn & Olof Solin

  2. Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark

    Lise Bentzen, Rumi Murata & Michael R. Horsman

  3. PET Centre and Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark

    Susanne Keiding

Authors
  1. Tove Grönroos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lise Bentzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Päivi Marjamäki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rumi Murata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael R. Horsman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Susanne Keiding
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Olli Eskola
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Merja Haaparanta
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Heikki Minn
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Olof Solin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tove Grönroos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grönroos, T., Bentzen, L., Marjamäki, P. et al. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 31, 513–520 (2004). https://doi.org/10.1007/s00259-003-1404-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1404-x

Keywords

Search

Navigation